Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality.
Platinum compounds with the diaminocyclohexane (dach) carrier ligand are of particular interest because cell lines that have developed resistance to platinum compounds in general often retain sensitivity to dach-platinum compounds, suggesting that the dach carrier ligand affects the formation, repair, or lethality of platinum-DNA adducts. The effect of the dach ligand on platinum adduct formation was assessed by using the (HaeIII-HindIII)146 fragment of pBR322 treated to give equal amounts of dach- or ethylene-diamine-platinum adducts. The sites of adduct formation were mapped by digestion with Escherichia coli ABC excinuclease. There were no significant effects of the dach carrier ligand on the types or sites of platinum adduct formation. The effect of the dach ligand on platinum adduct repair was determined by using synthetic oligomers designed to have single, specific platinum adducts (G monoadduct; GG, AG, or GNG diadduct) with either the dach or ethylenediamine (en) carrier ligand. These adducts differed significantly in their ability to serve as substrates for ABC excinuclease with GNG greater than or equal to G greater than AG greater than GG. The dach carrier ligand had little effect on the recognition of AG and GG adducts by ABC excinuclease, but significantly improved the ability of ABC excinuclease to excise G monoadducts and GNG diadducts. These data suggest that if the carrier ligand has any effect on the repair of platinum adducts, it is more likely to exert that effect on the repair of platinum monoadducts or GNG diadducts rather than on the more abundant AG or GG diadducts. [14C]Thiourea incorporation was used to quantitate the rate of monoadduct to diadduct conversion.(ABSTRACT TRUNCATED AT 250 WORDS)
Page
J D
JD
Department of Biochemistry and Curriculum in Toxicology, School of Medicine, University of North Carolina, Chapel Hill 27599-7260.
Husain
I
I
Sancar
A
A
Chaney
S G
SG
D001483:Base Sequence; D003514:Cyclohexylamines / Q000494:pharmacology*; D004249:DNA Damage; D004260:DNA Repair / Q000187:drug effects; D008024:Ligands; D008956:Models, Chemical; D008969:Molecular Sequence Data; D009841:Oligonucleotides / Q000138:chemical synthesis; D009944:Organoplatinum Compounds / Q000494:pharmacology*
D003514:Cyclohexylamines; D008024:Ligands; D009841:Oligonucleotides; D009944:Organoplatinum Compounds; C030435:1,2-cyclohexanediamine